Valneva SE

VLA

Company Profile

  • Business description

    Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

  • Contact

    6 Rue Alain Bombard
    Saint-Herblain44800
    FRA

    T: +33 228073710

    E: [email protected]

    https://www.valneva.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    713

Stocks News & Analysis

stocks

Wildly overvalued ASX stock is skating on thin ice

This company dominates its industry and could be flirting with regulatory intervention.
stocks

Uber flexes its network effect and delivers strong result

Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.
stocks

Ask the analyst: Are Qantas shares a value trap?

Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,102.009.10-0.10%
CAC 407,709.3274.290.97%
DAX 4024,192.50268.141.12%
Dow JONES (US)43,968.64224.48-0.51%
FTSE 1009,100.7763.54-0.69%
HKSE25,081.63171.000.69%
NASDAQ21,242.7073.270.35%
Nikkei 22541,059.15264.290.65%
NZX 50 Index12,876.0211.08-0.09%
S&P 5006,340.005.06-0.08%
S&P/ASX 2008,831.4012.30-0.14%
SSE Composite Index3,639.675.670.16%

Market Movers